Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells

Journal of Biological Chemistry

Volumn 287, Issue 24, 2012, Pages 20576-20589

  Asuthkar, Swapna ^a   Gondi, Christopher S ^a   Nalla, Arun Kumar ^a   Velpula, Kiran Kumar ^a   Gorantla, Bharathi ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRAY ANALYSIS; CANCER CELLS; CANCER STEM CELLS; CATENIN SIGNALING; CELL LINES; EMBRYONIC DEVELOPMENT; ENHANCER-BINDING PROTEINS; GENE TRANSCRIPTIONS; IN-VITRO; MEDULLOBLASTOMA; OVER-EXPRESSION; POTENT ACTIVATORS; REGULATORY RELATIONSHIPS; RESPONSE ELEMENTS; TRANSACTIVATION; UROKINASE PLASMINOGEN; UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTORS (UPAR);

BRAIN; CELL CULTURE; CHEMICAL ACTIVATION; DISEASES; FATTY ACIDS; GENES; IONIZING RADIATION; MOLECULES; PHENOLS; RECOMBINANT PROTEINS; STEM CELLS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

SIGNALING;

ACTIVATING ENHANCER BINDING PROTEIN 2ALPHA; BETA CATENIN; BINDING PROTEIN; CELL MARKER; HERMES ANTIGEN; LYMPHOID ENHANCER FACTOR; MUSASHI 1; QUERCETIN; SHORT HAIRPIN RNA; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; WNT7A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA RESPONSIVE ELEMENT; EMBRYO DEVELOPMENT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MEDULLOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MEMBRANE; CYTOPLASM; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDULLOBLASTOMA; MICE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA-BINDING PROTEINS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84862001767     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.348888     Document Type: Article

References (58)

1. Lannering, B., Sandström, P. E., Holm, S., Lundgren, J., Pfeifer, S., Samuelsson, U., Strömberg, B., Gustafsson, G., and Swedish Childhood CNS Tumor Working Group (VCTB) (2009) Classification, incidence, and survival analyses of children with CNS tumors diagnosed in Sweden 1984-2005. Acta Paediatr. 98, 1620-1627
2. Dhall, G. (2009) Medulloblastoma. J. Child Neurol. 24, 1418-1430
3. Romer, J., Nielsen, B. S., and Ploug, M. (2004) The urokinase receptor as a potential target in cancer therapy. Curr. Pharm. Des. 10, 2359-2376 (Pubitemid 38855042)
4. Sidenius, N., and Blasi, F. (2003) The urokinase plasminogen activator system in cancer. Recent advances and implication for prognosis and therapy. Cancer Metastasis Rev. 22, 205-222 (Pubitemid 36561058)
5. de Witte, J. H., Foekens, J. A., Brünner, N., Heuvel, J. J., van Tienoven, T., Look, M. P., Klijn, J. G., Geurts-Moespot, A., Grebenchtchikov, N., Benraad, T., and Sweep, C. G. (2001) Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumors. Br. J. Cancer 85, 85-92 (Pubitemid 32695721)
6. Gorantla, B., Asuthkar, S., Rao, J. S., Patel, J., and Gondi, C. S. (2011) Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Mol. Cancer Res. 9, 377-389
7. Killeen, S., Hennessey, A., El Hassan, Y., and Waldron, B. (2008) The urokinase plasminogen activator system in cancer. A putative therapeutic target? Drug News Perspect. 21, 107-116 (Pubitemid 351628235)
8. D'Alessio, S., Margheri, F., Pucci, M., Del Rosso, A., Monia, B. P., Bologna, M., Leonetti, C., Scarsella, M., Zupi, G., Fibbi, G., and Del Rosso, M. (2004) Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice. Int. J. Cancer 110, 125-133 (Pubitemid 38507212)
9. Lin, L., Gårdsvoll, H., Huai, Q., Huang, M., and Ploug, M. (2010) Structure-based engineering of species selectivity in the interaction between urokinase and its receptor. Implication for preclinical cancer therapy. J. Biol. Chem. 285, 10982-10992
10. Nalla, A. K., Asuthkar, S., Bhoopathi, P., Gujrati, M., Dinh, D. H., and Rao, J. S. (2010) Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma. PLoS One 5, e13006
11. Jo, M., Eastman, B. M., Webb, D. L., Stoletov, K., Klemke, R., and Gonias, S. L. (2010) Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells. Cancer Res. 70, 8948-8958
12. Fan, X., and Eberhart, C. G. (2008) Medulloblastoma stem cells. J. Clin. Oncol. 26, 2821-2827
13. Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y., Goumnerova, L. C., Black, P. M., Lau, C., Allen, J. C., Zagzag, D., Olson, J. M., Curran, T., Wetmore, C., Biegel, J. A., Poggio, T., Mukherjee, S., Rifkin, R., Califano, A., Stolovitzky, G., Louis, D. N., Mesirov, J. P., Lander, E. S., and Golub, T. R. (2002) Prediction of central nervous system embryonal tumoroutcome based on gene expression. Nature 415, 436-442 (Pubitemid 34100955)
14. Ellison, D. W., Onilude, O. E., Lindsey, J. C., Lusher, M. E., Weston, C. L., Taylor, R. E., Pearson, A. D., and Clifford, S. C. (2005) β-Catenin status predicts a favorable outcome in childhood medulloblastoma. The United Kingdom Children's Cancer Study Group Brain Tumor Committee. J. Clin. Oncol. 23, 7951-7957 (Pubitemid 46657395)
15. Logan, C. Y., and Nusse, R. (2004) The WNT signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810 (Pubitemid 39488658)
16. Mann, B., Gelos, M., Siedow, A., Hanski, M. L., Gratchev, A., Ilyas, M., Bodmer, W. F., Moyer, M. P., Riecken, E. O., Buhr, H. J., and Hanski, C. (1999) Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. U.S.A. 96, 1603-1608 (Pubitemid 29098498)
17. Jankun, J., Merrick, H. W., and Goldblatt, P. J. (1993) Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. J. Cell. Biochem. 53, 135-144 (Pubitemid 23294599)
18. Dumler, I., Stepanova, V., Jerke, U., Mayboroda, O. A., Vogel, F., Bouvet, P., Tkachuk, V., Haller, H., and Gulba, D. C. (1999) Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr. Biol. 9, 1468-1476 (Pubitemid 30023481)
19. Asuthkar, S., Nalla, A. K., Gondi, C. S., Dinh, D. H., Gujrati, M., Mohanam, S., and Rao, J. S. (2011) Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT. Neuro-oncol. 13, 1059-1073
20. Velpula, K. K., Dasari, V. R., Tsung, A. J., Dinh, D. H., and Rao, J. S. (2011) Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget 2, 1028-1042
21. Thomas, S., Chiriva-Internati, M., and Shah, G. V. (2007) Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling. Clin. Exp. Metastasis 24, 363-377 (Pubitemid 47134743)
22. Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H., Sioka, C., and Rao, J. S. (2005) Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J. Biol. Chem. 280, 21882-21892 (Pubitemid 40827839)
23. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658 (Pubitemid 37082259)
24. Lakka, S. S., Rajan, M., Gondi, C., Yanamandra, N., Chandrasekar, N., Jasti, S. L., Adachi, Y., Siddique, K., Gujrati, M., Olivero, W., Dinh, D. H., Kouraklis, G., Kyritsis, A. P., and Rao, J. S. (2002) Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21, 8011-8019 (Pubitemid 35434187)
25. Rich, J. N. (2007) Cancer stem cells in radiation resistance. Cancer Res. 67, 8980-8984
26. Dierick, H., and Bejsovec, A. (1999) Cellular mechanisms of wingless/WNT signal transduction. Curr. Top. Dev. Biol. 43, 153-190
27. Rezza, A., Skah, S., Roche, C., Nadjar, J., Samarut, J., and Plateroti, M. (2010) The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through WNT and Notch activation. J. Cell Sci. 123, 3256-3265
28. Behzadian, M. A., Windsor, L. J., Ghaly, N., Liou, G., Tsai, N. T., and Caldwell, R. B. (2003) VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J. 17, 752-754
29. Wong, N. A., and Pignatelli, M. (2002) β-Catenin. A linchpin in colorectal carcinogenesis? Am. J. Pathol. 160, 389-401
30. Ingraham, C. A., Park, G. C., Makarenkova, H. P., and Crossin, K. L. (2011) Matrix metalloproteinase (MMP)-9 induced by WNT signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels. J. Biol. Chem. 286, 17649-17657
31. Ragno, P. (2006) The urokinase receptor. A ligand or a receptor? Story of a sociable molecule. Cell. Mol. Life Sci. 63, 1028-1037
32. Nollet, F., Berx, G., Molemans, F., and van Roy, F. (1996) Genomic organization of the human& beta;-catenin gene (CTNNB1). Genomics 32, 413-424 (Pubitemid 26094344)
33. de Crozé N., Maczkowiak, F., and Monsoro-Burq, A. H. (2011) Reiterative AP2a activity controls sequential steps in the neural crest gene regulatory network. Proc. Natl. Acad. Sci. U.S.A. 108, 155-160
34. Kurashina, R., Ohyashiki, J. H., Kobayashi, C., Hamamura, R., Zhang, Y., Hirano, T., and Ohyashiki, K. (2009) Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via β-catenin/TCF7L2 pathway in adult T cell leukemia cells. Cancer Lett. 284, 62-70
35. Xiang, Y., Qin, X. Q., Liu, H. J., Tan, Y. R., Liu, C., and Liu, C. X. (2012) Identification of transcription factors regulating CTNNAL1 expression in human bronchial epithelial cells. PLoS One 7, e31158
36. Decary, S., Decesse, J. T., Ogryzko, V., Reed, J. C., Naguibneva, I., Harel-Bellan, A., and Cremisi, C. E. (2002) The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol. Cell. Biol. 22, 7877-7888 (Pubitemid 35217298)
37. Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., and Kleihues, P. (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol. 114, 97-109 (Pubitemid 47103521)
38. Eberhart, C. G., Tihan, T., and Burger, P. C. (2000) Nuclear localization and mutation of β-catenin in medulloblastomas. J. Neuropathol. Exp. Neurol. 59, 333-337 (Pubitemid 30183701)
39. Wu, B., Crampton, S. P., and Hughes, C. C. (2007) WNT signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26, 227-239 (Pubitemid 46329437)
40. Park, C. H., Chang, J. Y., Hahm, E. R., Park, S., Kim, H. K., and Yang, C. H. (2005) Quercetin, a potent inhibitor against β-catenin/TCF signaling in SW480 colon cancer cells. Biochem. Biophys. Res. Commun. 328, 227-234 (Pubitemid 40164659)
41. Saldanha, R. G., Xu, N., Molloy, M. P., Veal, D. A., and Baker, M. S. (2008) Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer. J. Proteome Res. 7, 4792-4806
42. Blasi, F., and Carmeliet, P. (2002) uPAR. A versatile signaling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932-943
43. Del Rosso, M. (2011) uPAR in angiogenesis regulation. Blood 117, 3941-3943
44. Jo, M., Takimoto, S., Montel, V., and Gonias, S. L. (2009) The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice. Am. J. Pathol. 175, 190-200
45. Rao, J. S., Gondi, C., Chetty, C., Chittivelu, S., Joseph, P. A., and Lakka, S. S. (2005) Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol. Cancer Ther. 4, 1399-1408
46. Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P. C., and Binder, B. R. (1997) Urokinase receptor is associated with the components of the JAK1/ STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272, 28563-28567 (Pubitemid 27517808)
47. Liu, D., Aguirre Ghiso, J., Estrada, Y., and Ossowski, L. (2002) EGFR is a transducer of the urokinase receptor-initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1, 445-457 (Pubitemid 41039125)
48. Mekkawy, A. H., De Bock, C. E., Lin, Z., Morris, D. L., Wang, Y., and Pourgholami, M. H. (2010) Novel protein interactors of urokinase-type plasminogen activator receptor. Biochem. Biophys. Res. Commun. 399, 738-743
49. Preissner, K. T., Kanse, S. M., and May, A. E. (2000) Urokinase receptor. A molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12, 621-628
50. Resnati, M., Pallavicini, I., Wang, J. M., Oppenheim, J., Serhan, C. N., Romano, M., and Blasi, F. (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. U.S.A. 99, 1359-1364 (Pubitemid 34136498)
51. Pratt, W. B., Galigniana, M. D., Harrell, J. M., and DeFranco, D. B. (2004) Role of hsp90 and the hsp90-binding immunophilins in signaling protein movement. Cell. Signal. 16, 857-872 (Pubitemid 38638776)
52. Pratt, W. B., and Toft, D. O. (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 228, 111-133 (Pubitemid 36187918)
53. Ruden, D. M., Xiao, L., Garfinkel, M. D., and Lu, X. (2005) Hsp90 and environmental impacts on epigenetic states. A model for the trans-generational effects of diethylstilbestrol on uterine development and cancer. Hum. Mol. Genet. 14, R149-R155 (Pubitemid 40542631)
54. Wang, Y. (2001) The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis. Med. Res. Rev. 21, 146-170
55. Gondi, C. S., Lakka, S. S., Yanamandra, N., Siddique, K., Dinh, D. H., Olivero, W. C., Gujrati, M., and Rao, J. S. (2003) Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene 22, 5967-5975 (Pubitemid 37175875)
56. Katoh, M., and Katoh, M. (2007) AP1- and NF-κB-binding sites conserved among mammalian WNT10B orthologs elucidate the TNFα-WNT10B signaling loop implicated in carcinogenesis and adipogenesis. Int. J. Mol. Med. 19, 699-703
57. Le Floch, N., Rivat, C., De Wever, O., Bruyneel, E., Mareel, M., Dale, T., and Gespach, C. (2005) The proinvasive activity of WNT-2 is mediated through a noncanonical WNT pathway coupled to GSK-3β and c-Jun/AP-1 signaling. FASEB J. 19, 144-146 (Pubitemid 40069946)
58. Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., Rømer, J., Solberg, H., Ellis, V., Danø, K., and Degen, J. L. (1995) The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem. 270, 16886-16894